According to Praxis Precision Medicines's latest financial reports the company has $81.3 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $81.3 M | -19.1% |
2022-12-31 | $0.10 B | -63.58% |
2021-12-31 | $0.27 B | -6.98% |
2020-12-31 | $0.29 B | 561.85% |
2019-12-31 | $44.81 M | 149.67% |
2018-12-31 | $17.95 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 156.07% | ๐บ๐ธ USA |